Sharon Weeks

Dr. Sharon Weeks

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in The Neurologist
Verified
Journal Article
Closed access
SWSharon Weeks
Sharon Weeks
VAVictoria C. Anderson-Barnes
Victoria C. Anderson-Barnes
JTJack W. Tsao
Jack W. Tsao
Since the beginning of the conflicts in Iraq and Afghanistan, there has been a dramatic increase in the number of military service members with single and multiple-limb amputations. Phantom limb pain (PLP) frequently develops in these individuals. As a result, identifying the best methods to treat PLP is critical. The review highlights areas of inquiry related to phantom pain, with a focus on PLP. This review discusses phantom sensations and phantom pain that arise after amputation of a body part, and summarizes the differences between the 2 conditions. Characteristics of PLP are also discussed, including the onset, duration, and location of PLP. Theories explaining the etiology and presence of PLP are reviewed, along with the numerous treatment options reported in the published data for such pain, including the use of mirrors for treating pain. We conclude with a description of one military hospital's experiences with PLP. Although more research has been done in previous years, this review identifies the need for continuing investigations. The etiology of PLP needs to be determined through more vigorous investigation, and a focus must be placed on defining treatment options in addition to mirror therapy that will improve the quality of life of those who suffer from this condition.

1 April 2018 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
SWSharon Weeks
Sharon Weeks
ZSZhaoli Sun
Zhaoli Sun
MMMary E. McCaul
Mary E. McCaul
HZHeng Zhu
Heng Zhu
RARobert A. Anders
Robert A. Anders
ACAndrew M. Cameron
Andrew M. Cameron
Six-month sobriety before transplantation for alcoholic liver disease is typically required but poorly supported by data. We initiated a pilot program after a report of liver transplantation for severe alcoholic hepatitis (SAH) in which the 6-month rule was waived. We previously reported early outcomes; we now provide longer follow-up in the largest cohort of early liver transplantation for SAH in the literature to date. Forty-six carefully selected patients with SAH underwent liver transplantation from October 2012 through July 2017; none had been abstinent for 6 months. We also examined 34 patients with alcoholic cirrhosis who received liver transplants under standard protocols with at least 6 months sobriety. We identified patient characteristics and primary outcomes of patient and graft survival, as well as alcohol recidivism. Secondary outcomes included post-transplantation infection, malignancy, and rejection. Compared with patients with alcoholic cirrhosis, SAH patients were younger and with shorter drinking history and higher Model for End-Stage Liver Disease scores at listing and at transplantation. Of these patients, 46% received preoperative steroids; all were nonresponders by Lille score. At a median follow-up time of 532 days (interquartile range 281 to 998 days), there were no significant differences between groups by log-rank testing of Kaplan-Meier estimates for patient and graft survival or alcohol recidivism. In the largest cohort of patients reported, outcomes after liver transplantation for SAH had excellent 1-year outcomes, similar to those seen in patients who received transplants with 6 months of sobriety. Recidivism was similar in the 2 groups. Early liver transplantation for SAH represents life-saving therapy for patients with otherwise high mortality, calling into question the utility of the 6-month rule in predicting outcomes in patients receiving transplants for alcoholic liver disease.

9 April 2014 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
SWSharon Weeks
Sharon Weeks
CJCatherine J. Juillard
Catherine J. Juillard
MMMartin E. Monono
Martin E. Monono
GEGeorges A. Etoundi
Georges A. Etoundi
MNMarquise K. Ngamby
Marquise K. Ngamby
KSKent A. Stevens
Kent A. Stevens

7 July 2017 in Frontiers in Neurology
Verified
Journal Article
Open access
SFSacha B. Finn
Sacha B. Finn
BPBriana N. Perry
Briana N. Perry
JCJay E. Clasing
Jay E. Clasing
LWLisa S. Walters
Lisa S. Walters
SJSandra L. Jarzombek
Sandra L. Jarzombek
JTJack W. Tsao
Jack W. Tsao
Objective: Phantom limb pain is prevalent in patients post-amputation and is difficult to treat. We assessed the efficacy of mirror therapy in relieving phantom limb pain in unilateral, upper extremity male amputees. Methods: Fifteen participants from Walter Reed and Brooke Army Medical Centers were randomly assigned to one of two groups: mirror therapy (n=9) or control (n=6, covered mirror or mental visualization therapy). Participants were asked to perform 15 minutes of their assigned therapy daily for 5 days/week for four weeks. The primary outcome was pain as measured using a 100-mm Visual Analogue Scale (VAS). Results: Subjects in the mirror therapy group had a significant decrease in pain scores, from a mean of 44.1 (SD=17.0) to 27.5 (SD=17.2) mm (p=0.002). In addition, there was a significant decrease in daily time experiencing pain, from a mean of 1022 (SD=673) to 448 (SD=565) minutes (p=0.003). In contrast, the control group had neither diminished pain (p=0.65) nor decreased overall time experiencing pain (p=0.49). A pain decrement response seen by the tenth treatment session was predictive of final efficacy. Conclusions: These results confirm that mirror therapy is an effective therapy for phantom limb pain in unilateral, upper extremity male amputees, reducing both severity and duration of daily episodes.

31 May 2010 in PM&R
Verified
Journal Article
Closed access
SWSharon Weeks
Sharon Weeks
CMCaitlin L. McAuliffe
Caitlin L. McAuliffe
DDDavid DuRussel
David DuRussel
PPPaul F. Pasquina
Paul F. Pasquina

1 September 2013 in Genetics
Verified
Journal Article
Open access
PDF file
ACAmy A Caudy
Amy A Caudy
YGYuanfang Guan
Yuanfang Guan
YJYue Jia
Yue Jia
CHChristina Hansen
Christina Hansen
CDChris DeSevo
Chris DeSevo
MDMaitreya J Dunham
Maitreya J Dunham
Whole-genome sequencing, particularly in fungi, has progressed at a tremendous rate. More difficult, however, is experimental testing of the inferences about gene function that can be drawn from comparative sequence analysis alone. We present a genome-wide functional characterization of a sequenced but experimentally understudied budding yeast, Saccharomyces bayanus var. uvarum (henceforth referred to as S. bayanus), allowing us to map changes over the 20 million years that separate this organism from S. cerevisiae. We first created a suite of genetic tools to facilitate work in S. bayanus. Next, we measured the gene-expression response of S. bayanus to a diverse set of perturbations optimized using a computational approach to cover a diverse array of functionally relevant biological responses. The resulting data set reveals that gene-expression patterns are largely conserved, but significant changes may exist in regulatory networks such as carbohydrate utilization and meiosis. In addition to regulatory changes, our approach identified gene functions that have diverged. The functions of genes in core pathways are highly conserved, but we observed many changes in which genes are involved in osmotic stress, peroxisome biogenesis, and autophagy. A surprising number of genes specific to S. bayanus respond to oxidative stress, suggesting the organism may have evolved under different selection pressures than S. cerevisiae. This work expands the scope of genome-scale evolutionary studies from sequence-based analysis to rapid experimental characterization and could be adopted for functional mapping in any lineage of interest. Furthermore, our detailed characterization of S. bayanus provides a valuable resource for comparative functional genomics studies in yeast.